Drug Research

Actylis, a global manufacturer of raw materials and performance ingredients for the life sciences and specialty chemicals markets, has opened a new 30,000 square foot cGMP facility in Eugene, OR. The multi-million dollar construction commenced in February of 2021...

AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...

Radiopharm Theranostics , a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that through its wholly owned subsidiary, Radiopharm Theranostics (USA) Inc., it has entered into a binding agreement to acquire Pharma15 Corporation...

Greenphire, the global leader when it comes to financial lifecycle management for clinical trials, recently announced the appointment of its new Chief Financial Officer, Owen Newman. Owen, who is adept in operations and financial management, comes with a rich experience of 25...

One of the most important trade fairs in the pharmaceutical industry will soon be taking place in Japan as it sees a huge resurgence in global trade with companies from the west, especially Switzerland, the USA, and the UK,...

Uppsala University researchers have created an artificial blood-brain barrier model that can be used to assess the efficacy of anti-body-based medicines while reducing animal experimentation. The treatment of protein clumps that happen to be prevalent in neurodegenerative illnesses is made...

Scientists from the University of Portsmouth have settled on a novel genetic link between Duchenne muscular dystrophy and cancer. Duchenne muscular dystrophy, which happens to be a muscle-wasting disease, is known to be caused by mutations when it comes...